CTRI/2024/02/063011尚未招募Unknown
A Multi-centric Trial to Evaluate the Efficacy of Electronic-Based Psychosocial Interventions on Future Suicide Risk among Adolescent Suicide Attempters.
ational Institutes of Health0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All adolescents who have attempted suicide within the last thirty days and presented to the study site
- •2. Between ages of 12–18 years
- •3. Participants of all gender will be included
- •3. Medically stable patients who have stable blood pressure, breathing rates without fever, and intact orientation to time, place, and person
排除标准
- •1. A current or a lifetime diagnosis of psychosis. We will confirm the same using a detailed clinical interview according to ICD-10 diagnostic guidelines.
- •2. A history of mental retardation and any neurological condition causing cognitive impairment.
- •3. A diagnosis of substance dependence as confirmed by M.I.N.I. KID 6.0 over the last six months. We will include those with tobacco dependence.
- •4. A diagnosis of serious medical illness like end-stage cancer, AIDS, less than a month following acute cardio-vascular and cerebrovascular events.
研究者
相似试验
尚未招募
不适用
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
已完成
不适用
A Safe and Non-invasive Breast Cancer Screening SolutioCTRI/2017/10/010115IRAMAI Health Analytix Pvt Ltd258
招募中
不适用
A Randomized, Multi-center Trial for the Effects of Dietary Instruction on Cardiovascular Risk Markers after Smoking Cessationicotine dependencyJPRN-UMIN000030282ational Hospital Organization Kyoto Medical Center250
招募中
2 期
Multicenter clinical trial to evaluate the efficacy of rituximab combination chemotherapy for children or AYAswith localized mature B-cell lymphomaJPRN-jRCTs041210104Sekimizu Masahiro100
进行中（未招募）
1 期
Multicentre clinical trial to evaluate the efficacy and safety of dexketoprofen trometamol (50 mg t.i.d.) versus ketorolac (30 mg t.i.d.) and placebo by intravenous route, as part of balanced analgesic therapy with morphine, followed by an oral dosing, in the treatment of postoperative paielective orthopedic surgery (hip arthroplasty)MedDRA version: 7.0Level: PTClassification code 10020096EUCTR2004-001373-26-ESaboratorios Menarini, S.A